BullFrog AI partners with Eleison to enhance Phase III trial
As per the agreement terms, BullFrog AI will offer access to AI solutions to improve trial efficiency and patient outcomes.
BullFrog AI and Eleison Pharmaceuticals Enter Agreement to Collaborate to Optimize Pivotal ...
BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the ...